Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients Meeting Abstract


Authors: Barrios, D. M.; Wang, D. G.; Blinder, V. S.; Bromberg, J.; Drullinsky, P.; Funt, S. A.; Jhaveri, K. L.; Lake, D.; Lyons, T.; Modi, S.; Razavi, P.; Sidel, M.; Traina, T. A.; Vahdat, L. T.; Lacouture, M. E.
Abstract Title: Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Start Page: 46s
Language: English
ACCESSION: WOS:000560368300284
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.1063
Notes: Meeting Abstract: 1063 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture
  2. Jacqueline Bromberg
    141 Bromberg
  3. Diana E Lake
    89 Lake
  4. Victoria Susana Blinder
    111 Blinder
  5. Tiffany A Traina
    250 Traina
  6. Shanu Modi
    265 Modi
  7. Komal Lachhman Jhaveri
    201 Jhaveri
  8. Linda T Vahdat
    43 Vahdat
  9. Pedram Razavi
    172 Razavi
  10. Samuel Aaron Funt
    135 Funt
  11. Dulce M Barrios
    13 Barrios
  12. Diana G Wang
    9 Wang
  13. Tomas Gerard Lyons
    10 Lyons